SAVLON DRY Cutaneous spray, powder Ref.[7985] Active ingredients: Cetrimide Chlorhexidine Povidone iodine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2014  Publisher: Novartis Consumer Health UK Ltd, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL Trading style: Novartis Consumer Health

Product name and form

Savlon Dry

Savlon Dry Antiseptic*

* Alternative name also applies throughout text.

Pharmaceutical Form

Cutaneous Spray, Powder.

Qualitative and quantitative composition

Povidone Iodine 1.14% w/w.

For excipients, see 6.1.

Active Ingredient Description

Cetrimide is a quaternary ammonium cationic disinfectant with bactericidal activity against gram-positive and some gram-negative organisms. Cetrimide is relatively ineffective against viruses.


Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high.

Povidone iodine

Povidone iodine is an iodophore that has an established use as a broad-spectrum antiseptic, mainly for the treatment of contaminated wounds and for the preoperative preparation of the skin, mucous membranes and the ocular surface. The organic complex contains approximately 10% of active available iodine. Solutions of povidone iodine gradually release iodine to exert an antimicrobial effect against bacteria, fungi, viruses, and spores. Although povidone iodine is less potent than preparations containing free iodine, it is also less toxic.

List of Excipients

Soya lecithin
Butane 40

Pack sizes and marketing

Monobloc aluminium aerosol container, internally lacquered, containing micronised powder and propellants under pressure and fitted with a valve and actuator and transparent yellow polypropylene overcap.

Marketing authorization holder

Novartis Consumer Health UK Ltd, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL

Trading style: Novartis Consumer Health

Marketing authorization dates and numbers

PL 00030/0124

15 April 1998


Drug Countries
SAVLON Ireland, Malta, Nigeria, New Zealand, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.